Inadequate Medication Side Effects in Psychiatrical Pathology

被引:0
|
作者
Furnica, Cristina [1 ]
Constantin, Maria-Magdalena Leon [1 ]
Chistol, Raluca Ozana [1 ,2 ]
Alexa, Anisia-Iuliana [1 ]
Constantin, Stefan [3 ]
Tinica, Grigore [1 ,2 ]
机构
[1] Grigore T Popa Univ Med & Pharm Iasi, Fac Med, Iasi 700115, Romania
[2] Inst Cardiovasc Dis Iasi, Iasi 700503, Romania
[3] Gheorghe Asachi Tech Univ Iasi, Elect Engn & Appl Informat Fac, Iasi 700050, Romania
来源
REVISTA DE CHIMIE | 2015年 / 66卷 / 11期
关键词
dopamine antagonist; dopamine partial agonist; aripiprazole; olanzapine; biochemical interactions; atypical antipsychotics; SCHIZOPHRENIA; NOREPINEPHRINE; OLANZAPINE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Atypical antipsychotic drugs are the first-line of therapy in adult schizophrenia but their effects in children and adolescents have not been well understood. In the current paper there is presented a case of early-onset schizophrenia (EOS) with complex prodromal symptoms for 6 months prior to the acute psychotic episode, followed by an aggravation of the condition with a suicidal attempt secondary to inadequate medication with a dopamine antagonist and a dopamine partial agonist. The patient finally responded to aripiprazole monotherapy with lack of psychiatric symptoms and improvement of social integration for over a year. In our opinion, a multidisciplinary approach involving the research of biochemical interactions between antipsychotic drugs may allow a better understanding of mental diseases, which in turn will contribute to the establishment of the most appropriate diagnostic and therapeutic scheme.
引用
收藏
页码:1864 / 1866
页数:3
相关论文
共 50 条
  • [31] Polypharmacy in neuroleptics side-effects comparison: a bias not to be overlooked
    Cabral Barata, Pedro
    EARLY INTERVENTION IN PSYCHIATRY, 2022, 16 (03) : 323 - 324
  • [32] Extrapyramidal side effects are unacceptable
    Kane, JM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 : 397 - 403
  • [33] Effects of antipsychotic medication on functional connectivity in major depressive disorder with psychotic features
    Neufeld, Nicholas H.
    Oliver, Lindsay D.
    Mulsant, Benoit H.
    Alexopoulos, George S.
    Hoptman, Matthew J.
    Tani, Hideaki
    Marino, Patricia
    Meyers, Barnett S.
    Rothschild, Anthony J.
    Whyte, Ellen M.
    Bingham, Kathleen S.
    Flint, Alastair J.
    Voineskos, Aristotle N.
    MOLECULAR PSYCHIATRY, 2023, 28 (08) : 3305 - 3313
  • [34] The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects
    Rasmussen, Sean A.
    Rosebush, Patricia I.
    Mazurek, Michael F.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (01) : 8 - 12
  • [35] Sleepwalking, A Possible Side Effect of Antipsychotic Medication
    Seeman, Mary V.
    PSYCHIATRIC QUARTERLY, 2011, 82 (01) : 59 - 67
  • [36] Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1)
    Peluso, Michael J.
    Lewis, Shon W.
    Barnes, Thomas R. E.
    Jones, Peter B.
    SCHIZOPHRENIA RESEARCH, 2013, 144 (1-3) : 80 - 86
  • [37] Blood lactate levels as a biomarker of antipsychotic side effects in patients with schizophrenia
    Elmorsy, Ekramy
    Shahda, Mohamed
    Mahmoud, El-Hassanen M.
    Rakha, Shirien A.
    Shoaib, Mohammed
    JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (01) : 63 - 68
  • [38] Interrater Reliability of the Modified Monitoring of Side Effects Scale for Assessment of Adverse Effects of Psychiatric Medication in Clinical and Research Settings
    Nugent, Katie L.
    Spahr, Erin
    Toroney, Jaimie
    Mojtabai, Ramin
    Nettles, Carrie
    Turner, Lydia W.
    Fenton, Ashley
    Spivak, Amethyst
    Cullen, Bernadette A.
    Everett, Anita
    Eaton, William W.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 324 - 328
  • [39] Sleepwalking, A Possible Side Effect of Antipsychotic Medication
    Mary V. Seeman
    Psychiatric Quarterly, 2011, 82 : 59 - 67
  • [40] The protective effect of thymoquinone over olanzapine-induced side effects in liver, and metabolic side effects
    Bilgic, S.
    Korkmaz, Tastemir D.
    Azirak, S.
    Guvenc, A. N.
    Kocaman, N.
    Ozer, M. K.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2017, 118 (10): : 618 - 625